You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

October 8, 2019

Court Issues Trailblazing Verdict in Vietnam Patent Case

Managing Intellectual Property

Intellectual property litigation attorneys, especially those in the patent field, are always looking for verdicts that can be viewed as landmarks in the interpretation and practical application of Vietnam’s laws and regulations. One such verdict was issued by the People’s Court of Binh Duong Province on July 17, 2019, in a patent infringement case between a European pharmaceutical company and one of Vietnam’s largest manufacturers of generic drugs. The court’s judgment provided a number of tantalizing “firsts” in terms of legal milestones, addressing a number of questions about provisions found in legal documents that had previously never been enforced in practice.

Validity of foreign expert opinions

The first question answered was whether expert opinions from abroad would be accepted in proceedings in Vietnam. Specifically, because the allegedly infringed patent in this case protected a chemical substance that could only be identified by x-ray diffraction, a sample of the suspect product was sent abroad for analysis, as there were no machines qualified to carry out such work in Vietnam. The analysis results were then compiled in a report which was submitted to Vietnam’s patent assessment agency, which relied on the results to issue its own expert opinion, under which the assessed product was deemed to be identical to the patented substance, and thus infringing.

The defendant asked the court to reject the opinions of foreign experts. However, in the course of preparing for the trial, the court consulted the assessment agency, and the agency responded that, within the scope of its jurisdiction, it could refer to any documents that it considered appropriate, including this expert opinion from abroad.

Of all the patent cases resolved in Vietnam so far, it seems this is the first time the legal validity of a foreign expert opinion has been raised. This verdict, with the assessment agency’s confirmation of the legal validity of foreign expert opinions, may create a precedent for other agencies to consider in similar cases.

Does statutory compensation require evidence?

Vietnam’s IP laws provide principles for determining compensation for damages in both general provisions and specific provisions—which are sometimes completely at odds with each other. For example, the general provisions on statutory compensation in tort under the current civil law state that the damages to be compensated must be, or are limited to, only actual damages, and they must be fully and promptly compensated (Article 585.1 of the 2015 Civil Code). However, the “statutory” compensation prescribed in Article 205.1(c) of the Law on Intellectual Property permits the court to set an arbitrary compensation level of not more than VND 500 million if damages cannot be quantified based on usual grounds, such as monetary damages incurred by the plaintiff, or the price of the assignment of IP rights if the defendant is an assignee.

In patent cases, where most of the plaintiffs are foreign entities and the defendants are Vietnamese companies, due to many obstacles such as a lack of accounting books or damages that cannot be specifically quantified, the plaintiffs often request the court to apply the provisions on statutory compensation levels in their judgments. However, these provisions are often interpreted and applied completely differently in practice. Even in the courts of large localities like Hanoi or Ho Chi Minh City, judges tend to consider the provisions on “statutory” compensation to be the general provisions; that is, the plaintiffs are still required to prove a specific amount of damages to be accepted or rejected. Such a view clearly contains internal contradictions when the law provides specific provisions on statutory compensation for unprovable and unquantifiable damages. Therefore, the July 17 verdict is significant in that the court, after determining that patent infringement was committed, approved the application of statutory compensation at the maximum level of VND 500 million.

Relationships between general law and specialized law

Another interesting point in the July 17 verdict is that the court completely rejected the defendant’s argument to suspend the case until the patent office resolved a patent cancellation request that the defendant had filed right before the trial opened, in a last-gasp attempt. (The resolution of such a case can take years.)

At the trial, the defendant requested the court to suspend the case on the grounds of the 2015 Civil Procedure Code. However, in an unexpected action, the court compared the Civil Procedure Code to the Law on Intellectual Property to determine which law should prevail in considering whether to suspend the case. After that, both the court and the procuracy agreed that the Law on Intellectual Property should prevail, because it is a specialized law in relation to the general law of the Civil Procedure Code.

The court then concluded that there were no provisions in the Law on Intellectual Property requiring the court to suspend the case. Therefore, the court decided to move forward with the trial and issued a verdict. This method of relying on the relation between the general law and the specialized law is truly a very new point in Vietnam.

The court’s verdict in this case shows that even though IP enforcement in Vietnam has many limitations in the big picture, there are still cases that can leave positive marks.

RELATED INSIGHTS​ 

September 7, 2026
Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability. The decision took effect immediately upon its pronouncement at the court’s plenary session on August 28, 2026. Background The petition challenged the removal of article 4(f) from Law No. 13 of 2016 concerning Patents (Patent Law), as amended by Law No. 65 of 2024. Article 4(f) had excluded from patentability certain inventions relating to new uses of known substances. The petitioners argued that removing this provision would open the door to patent protection for second medical use inventions and facilitate patent evergreening—practices that can extend exclusivity periods, delay generic market entry, and reduce public access to affordable medicines. The petitioners included several patient advocacy and public-interest organizations: the Indonesian Dialysis Patients Community Association, the Indonesian Association of Drug Abuse Victims (PKNI), the Indonesian Pulmonary Hypertension Foundation (YHPI), the Rekat Peduli Indonesia Foundation, and the Indonesian Positive Women’s Association (IPPI), along with the Indonesia for Global Justice Association and four individual petitioners. The petitioners also challenged the constitutionality of the phrase “interested party” in article 70(1) of the Patent Law, arguing that it should be construed expressly to clarify who has standing to appeal a decision to grant a patent before the Board of Patent Appeal, and to allow a broader range of parties—such as patent holders, licensees, consumer organizations, prosecutors, aggrieved third parties, and others who may suffer direct or indirect harm from the grant of a patent—to
September 2, 2026
Thailand and China have a longstanding and significant trade relationship, which increasingly extends to e-commerce and digitally enabled supply chains. While these channels create new opportunities for businesses to reach consumers across borders, their growth also brings greater exposure to intellectual property (IP) infringement across jurisdictions and online platforms. Effective cooperation between the two countries’ enforcement authorities has therefore become increasingly important. To strengthen cooperation in this area, Thailand and China signed a memorandum of understanding (MOU) on IP enforcement in Beijing on July 20, 2026, during the Thai prime minister’s official visit to China. Officially titled “Memorandum of Understanding Between the State Administration for Market Regulation of the People’s Republic of China and the Ministry of Commerce of the Kingdom of Thailand on Cooperation in the Field of Intellectual Property Enforcement,” the MOU forms part of a broader bilateral agenda covering industrial and supply chains, participation by micro, small, and medium-sized enterprises (MSMEs), cooperation associated with the ASEAN–China Free Trade Area 3.0, and progress on the registration of Thai geographical indications in China. The MOU establishes a bilateral framework for cooperation and coordination in five broad areas: Strengthening dialogue in IP enforcement; Enhancing information sharing; Facilitating the enforcement of IP rights in cases arising in the parties’ domestic markets and on online platforms, in accordance with their respective domestic laws; Promoting cooperation in IP enforcement training and human resource development; and Undertaking other cooperation activities agreed upon by both sides. The Department of Intellectual Property (DIP) will serve as the principal coordinating agency for Thailand, while the Bureau of Law Enforcement and Inspection in China’s State Administration for Market Regulation (SAMR) will serve in that role for China. The framework is particularly relevant to the growth of e-commerce, as it covers infringement in the domestic markets and on
August 28, 2026
When considering a franchise, many people first think of a restaurant, retail chain, or service outlet. From a legal perspective, however, the foundation of every franchise lies in the right to use a brand, which is typically granted through a trademark license. Trademarks are often the most valuable assets in a franchise system. Through a trademark license, a franchisor authorizes a franchisee to use its trademarks, logos, and branding while maintaining control over how the brand is presented to customers. The Role of Trademarks in Franchise Businesses Under the Trademark Law 2019, a mark is defined as a sign that is capable of distinguishing the goods or services of one undertaking from those of others in the course of trade. This distinguishing function is particularly important in a franchise arrangement, where the franchisee’s use of the franchisor’s trademark allows consumers to recognize the source, quality, and reputation of the business. In this way, trademarks help preserve brand identity, strengthen market recognition, and protect the commercial value of the franchise system. Legal Foundation for Franchise Brand Protection Myanmar presently does not have a specific statutory framework governing franchise arrangements. As a result, franchise agreements are generally regulated under the broader applicable legal framework, including the Contract Act 1872, the Trademark Law 2019, the Competition Law 2015, the Consumer Protection Law 2019, and the relevant implementing rules and regulations. The licensing of trademarks within a franchise arrangement is particularly governed by the Trademark Law 2019. Franchisors should ensure that the trademarks intended to be licensed to franchisees in Myanmar are registered under the Trademark Law 2019 and that the relevant trademark license is properly recorded with the Intellectual Property Department (IPD). Trademark License Recordal Under the Trademark Law 2019, the owner of a registered trademark may grant a license to another
August 27, 2026
It is generally understood that patents are granted for new designs that have not been widely known or used in Thailand and not been disclosed anywhere prior to the date of the patent application. It is trite law that design law protects the distinctive appearance or products. Under Section 3 of the Thai Patent Act B.E. 2522, as amended by the Patent Act (No. 2) B.E. 2535 and the Patent Act (No. 3) B.E. 2542, a design is defined as “any form or composition of lines or colors that gives a product a special appearance and can serve as a pattern for an industrial or handicraft product.” This raises an important question. Can a patent be issued for a product design that contains text, numerals, trademarks, or symbols that do not fall under the definition of a design? This issue commonly arises when attempting to register packaging, labels, and graphical user interfaces (GUIs). Until a few years ago, applicants could file design applications with the Thai Patent Office for designs that contained such elements, provided that an appropriate disclaimer was included. This practice was generally accepted by Thai design examiners at that time, but the Patent Office has since implemented a change in its practice that could have a significant impact on applicants for design patents. Where design representations are submitted as line drawings or computer-aided design (CAD) drawings, the examiner may now issue an office action requiring their removal. This practice, however, appears to be applied inconsistently, as some examiners still exercise their own discretion in determining whether drawings containing these elements are acceptable. Below are examples of a GUI design, a CAD drawing design, and a photographic design representation that illustrates issues relating to the presence of nonallowable elements. GUI design For this GUI design, the submitted